ESR1 and breast cancer: The association between testosterone and breast cancer risk was strengthened after adjustment for estradiol concentrations (ER–/PR- ORlog2: 0.64 (95% CI: 0.33–1.25); ER+/PR+ ORlog2: 1.64 (1.15–2.33)).